Free Trial

Surmodics (SRDX) Competitors

Surmodics logo
$36.00 +3.95 (+12.32%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$38.12 +2.13 (+5.90%)
As of 07/25/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SRDX vs. ATEC, ATRC, IART, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRG

Should you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), ORTHOFIX MEDICAL (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.

Surmodics vs. Its Competitors

Alphatec (NASDAQ:ATEC) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

Surmodics has lower revenue, but higher earnings than Alphatec. Surmodics is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$611.56M2.59-$162.12M-$1.15-9.41
Surmodics$121.58M4.23-$11.54M-$1.39-25.90

Alphatec currently has a consensus target price of $18.13, suggesting a potential upside of 67.51%. Surmodics has a consensus target price of $43.00, suggesting a potential upside of 19.44%. Given Alphatec's stronger consensus rating and higher possible upside, equities research analysts plainly believe Alphatec is more favorable than Surmodics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Surmodics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Alphatec had 2 more articles in the media than Surmodics. MarketBeat recorded 6 mentions for Alphatec and 4 mentions for Surmodics. Surmodics' average media sentiment score of 0.71 beat Alphatec's score of 0.44 indicating that Surmodics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Surmodics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Surmodics has a net margin of -16.34% compared to Alphatec's net margin of -25.77%. Surmodics' return on equity of -7.10% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-25.77% -1,657.19% -21.53%
Surmodics -16.34%-7.10%-4.77%

66.4% of Alphatec shares are held by institutional investors. Comparatively, 96.6% of Surmodics shares are held by institutional investors. 20.9% of Alphatec shares are held by insiders. Comparatively, 8.9% of Surmodics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Alphatec has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500.

Summary

Alphatec and Surmodics tied by winning 8 of the 16 factors compared between the two stocks.

Get Surmodics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRDX vs. The Competition

MetricSurmodicsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$458.28M$10.55B$5.70B$9.50B
Dividend YieldN/A2.00%4.60%4.01%
P/E Ratio-25.9017.0728.1020.05
Price / Sales4.2329.18429.3789.38
Price / Cash103.5923.0336.2258.56
Price / Book4.323.698.665.87
Net Income-$11.54M$234.77M$3.25B$258.55M
7 Day Performance19.17%6.32%4.22%3.73%
1 Month Performance23.75%7.94%10.51%11.75%
1 Year Performance-13.13%-13.57%34.40%18.03%

Surmodics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRDX
Surmodics
4.0254 of 5 stars
$36.00
+12.3%
$43.00
+19.4%
-13.4%$458.28M$121.58M-25.90450News Coverage
Upcoming Earnings
High Trading Volume
ATEC
Alphatec
3.9107 of 5 stars
$10.31
-1.7%
$18.13
+75.8%
-0.5%$1.53B$611.56M-8.97700News Coverage
Positive News
Upcoming Earnings
ATRC
AtriCure
3.3316 of 5 stars
$29.24
-0.1%
$50.67
+73.3%
+33.9%$1.45B$465.31M-36.101,300News Coverage
Positive News
Upcoming Earnings
IART
Integra LifeSciences
4.1407 of 5 stars
$11.37
+2.2%
$18.63
+63.8%
-58.4%$864.94M$1.61B4.604,396News Coverage
Upcoming Earnings
OFIX
ORTHOFIX MEDICAL
2.7408 of 5 stars
$10.67
+0.4%
$21.50
+101.5%
-31.7%$416.49M$799.49M0.001,616
ANGO
AngioDynamics
3.9515 of 5 stars
$8.99
+3.5%
$19.00
+111.3%
+22.8%$352.88M$292.50M-10.83760
ARAY
Accuray
3.1256 of 5 stars
$1.34
+0.4%
N/A-27.3%$137.52M$446.55M0.001,040News Coverage
Positive News
RMTI
Rockwell Medical
3.9965 of 5 stars
$1.12
+1.8%
$4.00
+257.1%
-42.2%$37.59M$101.49M0.00300Positive News
RSLS
ReShape Lifesciences
0.4256 of 5 stars
$2.91
-8.5%
N/A-99.2%$7.59M$8.01M0.0050Positive News
ABT
Abbott Laboratories
4.9902 of 5 stars
$124.27
+0.5%
$144.47
+16.3%
+19.4%$215.17B$41.95B15.57114,000
ISRG
Intuitive Surgical
4.7034 of 5 stars
$516.12
-0.5%
$592.86
+14.9%
+13.5%$185.88B$8.35B81.4215,638Trending News
Earnings Report
Analyst Forecast
Insider Trade
Analyst Revision

Related Companies and Tools


This page (NASDAQ:SRDX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners